The Cutting Edge of Medical Technology Content, Community & Collaboration
Maryland Dept of Business & Economic Devt Nominee Revs Up for Race to Top
Colleagues,
As reported in GenomeWeb, BioRegions...BioRegion News recently spoke with incoming Maryland Secretary of the Department of Business and Economic Development (DBED), Christian S. Johansson about his vision for DBED and the broader challenge of elevating Maryland's life sciences effort.
Gov. Martin O'Malley's 15-member Life Science Advisory Board will release its strategic plan for catapulting Maryland's biocluster into the stratosphere occupied by a handful of states that include California, Massachusetts, and North Carolina.
One key strategic plank has already been made public: Consultant Battelle Memorial Foundation recommended that Maryland focus on five technology platforms: biopharmaceuticals, contract bioscience research services, molecular diagnostics and personalized medicine, biodefense and emerging infectious diseases, and "bio-based" products such as biofuels.
The anchor initiative of that plan will be the planned Maryland Biotechnology Center, a one-stop shop for life-sci companies seeking to relocate to or expand within the state, which would operate on $91.5 million over the next decade.
Following is an edited transcript of that interview:
Read on at: http://www.genomeweb.com/bioregionnews/qa-govt-academic-pole-positi...
ENJOY!
CC
As reported in GenomeWeb, BioRegions...BioRegion News recently spoke with incoming Maryland Secretary of the Department of Business and Economic Development (DBED), Christian S. Johansson about his vision for DBED and the broader challenge of elevating Maryland's life sciences effort.
Gov. Martin O'Malley's 15-member Life Science Advisory Board will release its strategic plan for catapulting Maryland's biocluster into the stratosphere occupied by a handful of states that include California, Massachusetts, and North Carolina.
One key strategic plank has already been made public: Consultant Battelle Memorial Foundation recommended that Maryland focus on five technology platforms: biopharmaceuticals, contract bioscience research services, molecular diagnostics and personalized medicine, biodefense and emerging infectious diseases, and "bio-based" products such as biofuels.
The anchor initiative of that plan will be the planned Maryland Biotechnology Center, a one-stop shop for life-sci companies seeking to relocate to or expand within the state, which would operate on $91.5 million over the next decade.
Following is an edited transcript of that interview:
Read on at: http://www.genomeweb.com/bioregionnews/qa-govt-academic-pole-positi...
ENJOY!
CC
Views: 3
MedTechIQ VideoLibrary
Upcoming Events
© 2024 Created by CC-Conrad Clyburn-MedForeSight.
Powered by
